JP2009247334A - Carrier for cell culture - Google Patents

Carrier for cell culture Download PDF

Info

Publication number
JP2009247334A
JP2009247334A JP2008103472A JP2008103472A JP2009247334A JP 2009247334 A JP2009247334 A JP 2009247334A JP 2008103472 A JP2008103472 A JP 2008103472A JP 2008103472 A JP2008103472 A JP 2008103472A JP 2009247334 A JP2009247334 A JP 2009247334A
Authority
JP
Japan
Prior art keywords
cell culture
cells
carrier
cell
culture carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008103472A
Other languages
Japanese (ja)
Inventor
Reishi Nishio
玲士 西尾
Takao Aoki
孝夫 青木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP2008103472A priority Critical patent/JP2009247334A/en
Publication of JP2009247334A publication Critical patent/JP2009247334A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/10Hollow fibers or tubes

Abstract

<P>PROBLEM TO BE SOLVED: To solve a problem that, though particle-like beads, hollow fibers and the like are brought into practical use to secure surface areas for adhesion in a large scale culture of adherent cells, those methods are in lack of simplicity with bad efficiency in sowing cells, requirement of specific processes for sowing the cells and the like and are accompanied with difficulty in industrially using the adherent cells. <P>SOLUTION: A carrier for cell culture is provided. The carrier is a solid body made by cutting external portions of a minute hollow body having the external shape of a sphere, an ellipsoid, a polyhedron, a cylinder or a pyramid and a 50-2,000 μm maximum major diameter and a maximum length perpendicular to the maximum major diameter, has an inner wall to a hollow part of which adherent cells can adhere, 5-40% opening on the external shape surface connecting the external space with the hollow part. A method for culturing adherent cells is also provided using the carrier for culturing cells. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は細胞培養担体および本発明の細胞培養担体を用いて細胞を培養する方法に関するものである。   The present invention relates to a cell culture carrier and a method for culturing cells using the cell culture carrier of the present invention.

近年、生体からの細胞単離技術、細胞培養技術、細胞保存技術の進歩とともに、細胞を様々な用途に利用する検討が進められている。最も広範に産業利用されている技術は細胞を用いて細胞生育生産物の製造を行うバイオ生産である。例を挙げるとインターフェロンの生産や、モノクローナル抗体の生産、各種ウイルスベクターの生産などがあり、これに限らず様々な産業応用がなされている。また、この他にも医薬の開発や生命活動の研究において高価な実験動物に代わりハイスループットで薬物をスクリーニングする方法として細胞を用いたアッセイが行われている。また、細胞そのものを医療に用いる細胞医療の試みも進められている。   In recent years, with the progress of cell isolation technology, cell culture technology, and cell storage technology from living organisms, studies are underway to utilize cells for various purposes. The technology that is most widely used in industry is bioproduction in which cells are used to produce cell growth products. Examples include the production of interferon, the production of monoclonal antibodies, the production of various viral vectors, and the like, and various industrial applications are made. In addition, in the development of medicines and research on life activities, assays using cells are performed as a method for screening drugs with high throughput instead of expensive experimental animals. Attempts have also been made for cell therapy using cells themselves for medical treatment.

このように多くの分野で細胞の産業応用が進められているが、これらの試みの多くは浮遊状態で細胞の生存を維持できる非接着系細胞により行われている。これに属さない接着系細胞は細胞の生存を維持するために足場に接着する必要があり、細胞の生存維持、高密度状態での培養・細胞の取り扱いの点において非接着系細胞よりも利便性に劣る。例えば、バイオ生産においては可能な限り高密度で細胞を培養することが望ましく、この点で浮遊・懸濁状態での培養が可能な非接着系細胞が好まれる。   Thus, industrial applications of cells are being promoted in many fields, but many of these attempts are performed by non-adherent cells that can maintain cell survival in a floating state. Adherent cells that do not belong to this cell need to adhere to the scaffold to maintain cell survival, and are more convenient than non-adherent cells in terms of maintaining cell survival, culturing and handling cells at high density. Inferior to For example, in bioproduction, it is desirable to culture cells at as high a density as possible. In this respect, non-adherent cells that can be cultured in a suspended / suspended state are preferred.

近年、ゲノム解析、プロテオーム解析の研究の進展とともに哺乳類細胞や昆虫細胞など多細胞生物の体内より有用な細胞生育生産物が多数発見されているが、これらの細胞生育生産物を製造するためには多細胞生物由来の接着系細胞を必要とする場合もあり、これらの細胞生育生産物の生産には非接着系細胞で用いられている攪拌培養法を直接用いることは出来ない。   In recent years, with the progress of research on genome analysis and proteome analysis, many useful cell growth products have been discovered from the inside of multicellular organisms such as mammalian cells and insect cells, but in order to produce these cell growth products Adhesive cells derived from multicellular organisms may be required, and the agitation culture method used for non-adherent cells cannot be used directly for the production of these cell growth products.

接着系細胞を浮遊状態で生存維持し培養することが出来れば接着系細胞を非接着系細胞と同様に扱うことが可能になるが、このようなことを実現させるために細胞培養担体が考案されている(特許文献1)。   Adhesive cells can be handled in the same way as non-adherent cells if they can be maintained and cultured in a suspended state. To achieve this, a cell culture carrier has been devised. (Patent Document 1).

このような細胞培養担体としては、これまでに様々な材質から構成される担体が考案されている。担体上に接着系細胞を接着させ、粒子表面で増殖し、この粒子ごと培養することで、培養槽中の細胞の接着可能な表面積を拡大させ、細胞培養密度を向上させる事ができる。   As such cell culture carriers, carriers composed of various materials have been devised so far. By adhering adherent cells on the carrier, growing on the surface of the particles, and culturing the particles together, the surface area of the cells in the culture tank where the cells can adhere can be increased, and the cell culture density can be improved.

最初に考案された細胞培養担体は単純な球形の担体であったが、このような担体の表面は凸面の接着面を持ち、そこに接着する細胞は広く伸展した形態をとらざるを得ない。このような状態は細胞に正常で無い状態を作り出し細胞の増殖速度、生存率、細胞生育生産物の産生量を低下させることが知られている。またこのような凸面表面への細胞の初期接着効率は悪く、細胞播種後、細胞を粒子全体に成長させるまでに時間がかかる。   The cell culture carrier originally devised was a simple spherical carrier, but the surface of such a carrier has a convex adhesive surface, and the cells adhering to it have to take a widely extended form. It is known that such a state creates an abnormal state in the cell and reduces the cell growth rate, the survival rate, and the production amount of the cell growth product. In addition, the initial adhesion efficiency of the cells to such a convex surface is poor, and it takes time to grow the cells to the whole particles after seeding the cells.

また、生体内より摘出した哺乳類正常細胞の多くは、細胞の接着、生存、増殖にサイトカインなどの自己産生型可溶性物質を必要とするものも多く、初期に用いられていた細胞培養担体のように細胞播種時に細胞の密度が著しく低くなり、自己産生されたサイトカインが分散してしまう培養方法では細胞の播種、効率的な増殖、培養に困難が伴った。   In addition, many of the normal mammalian cells removed from the living body require many self-produced soluble substances such as cytokines for cell adhesion, survival, and proliferation, such as the cell culture carriers used in the early days. In the culture method in which the density of cells becomes extremely low at the time of cell seeding and the self-produced cytokine is dispersed, it is difficult to seed, efficiently proliferate, and culture the cells.

さらに担体表面に細胞を接着させるこれらの細胞培養担体は、懸濁培養する際に、担体と培養槽、または担体同士との接触により細胞が物理的ダメージを受けてしまうことが避けらず、攪拌速度や、培養密度が制限される問題があった。   Furthermore, these cell culture carriers that adhere cells to the surface of the carrier are unavoidably subject to physical damage to the cells due to contact between the carrier and the culture tank or between the carriers during suspension culture. There was a problem that speed and culture density were limited.

細胞培養担体はさらに改良が進められており、細胞の高密度培養を目指してポリウレタンなどを用いた発泡素材により形成された多孔質の細胞培養担体(特許文献2)、セルロース繊維や炭素繊維等(特許文献3)の細胞の入り込む隙間を多数持った小片からなる細胞培養担体などが考案されている。   Cell culture carriers have been further improved, and porous cell culture carriers (Patent Document 2) formed from foamed materials using polyurethane or the like for high-density culture of cells (Patent Document 2), cellulose fibers, carbon fibers, etc. ( A cell culture carrier composed of small pieces having a large number of gaps into which cells are introduced has been devised.

これらの担体では接着させた細胞の一部が担体の内部の孔に入り込むため、球状の細胞培養担体と比較し、鈍角の接着面による細胞への悪影響や、担体同士や、担体と培養槽との接触による細胞への物理的ダメージを抑えることができる。   In these carriers, some of the adhered cells enter the pores inside the carriers, so compared to spherical cell culture carriers, the negative effects on the cells due to the obtuse angle of the adhesion surface, between the carriers, between the carriers and the culture tank Physical damage to the cells due to contact with can be suppressed.

しかし、この種類の担体は細胞が進入可能な担体内部へと続く孔を厳密に制御することが困難であり、広い内部壁面を持つ担体であっても、その内部壁面へと通じる孔は無秩序に形成されたものであり、培養時には存在する内部壁面のほんの一部のみが利用される。また、細胞導入経路は無秩序に形成された孔を通じて行うことが必要であり、よく行われる方法としては細胞分散液と担体を混合し、懸濁時に一部が孔に導入される方法が行われる。これらの効率を向上させるために間欠攪拌法やフィコール法(非特許文献1)が知られるが、これらの方法も満足できる導入効率を持つものでは無く、担体の持つ内部壁面すべてに効率的に細胞を導入できる方法では無かった。   However, with this type of carrier, it is difficult to strictly control the pores that enter the inside of the carrier where cells can enter, and even if the carrier has a wide inner wall surface, the pores leading to the inner wall surface are disorderly. Only a part of the inner wall surface that is formed and is present during culture is used. In addition, the cell introduction route needs to be performed through randomly formed pores, and a common method is to mix a cell dispersion and a carrier and introduce a part into the pores when suspended. . In order to improve these efficiencies, the intermittent stirring method and Ficoll method (Non-patent Document 1) are known, but these methods do not have satisfactory introduction efficiency, and the cells are efficiently applied to all the inner wall surfaces of the carrier. It was not the method that can be introduced.

このような細胞導入の困難な細胞培養担体への細胞導入を効率的に行うことを目指し担体内部への溶液の浸透と除去を繰り返し行う方法(特許文献4)や陰圧にしたチャンバーを利用し強制的に細胞を担体内部に導入する方法(特許文献5)などいくつかの方法が考案されているが、導入のための装置が必要であったり、導入のために細胞へのある程度のダメージが予想されるなど、いずれの方法も培養初期段階での作業工程を増加させるものであった。   In order to efficiently introduce cells into a cell culture carrier that is difficult to introduce such cells, a method of repeatedly infiltrating and removing the solution from the inside of the carrier (Patent Document 4) and a chamber under negative pressure are used. Several methods have been devised, such as a method for forcibly introducing cells into the carrier (Patent Document 5), but a device for introduction is required, or some damage to the cells is caused by the introduction. As expected, both methods increased the number of work steps in the initial stage of culture.

また、接着系細胞を高密度に培養する方法としては、中空糸を用いた培養がある。束にした中空糸の内部、または外部に細胞を充填し、培養液を循環させることで高密度に集積培養された細胞による細胞生育生産物の生産を行うことができる(特許文献6)。この仕組みを利用し中空糸の中に大量の肝細胞を培養し、患者血液を循環させる「中空糸型人工肝臓」の実現を目指す試みもある。   As a method for culturing adherent cells at high density, there is a culture using hollow fibers. Cell growth products can be produced by cells densely integrated and cultured by filling cells inside or outside the bundled hollow fibers and circulating the culture solution (Patent Document 6). There is also an attempt to realize a “hollow fiber type artificial liver” that cultivates a large amount of hepatocytes in a hollow fiber and circulates patient blood using this mechanism.

これらの中空糸を使用した細胞培養方法は高い培養密度を実現可能な方法ではあるが、長い中空糸へ細胞充填は、送液と共に細胞を送りこむことが必要で高度に制御された装置と方法が必要であった。また中空糸内に培養された細胞を培養するためには強制的に細胞培養液を循環させる必要があり、この制約のため、バイオ生産プラント、人工臓器モジュールは、周辺の補助装置も含め、複雑で大規模なものに成らざるを得ない点が問題となっている。
特開平4−360682 特開平4−281784 特開2004−135668 特開2006−25635 特開2006−812468 特開2003−180334 大石道夫 監修 「動物細胞培養技術と物質生産」2002年シーエムシー出版
Although the cell culture method using these hollow fibers is a method capable of realizing a high culture density, cell filling into a long hollow fiber requires a highly controlled apparatus and method that requires cells to be fed together with the liquid feeding. It was necessary. In addition, in order to cultivate cells cultured in hollow fibers, it is necessary to circulate the cell culture solution forcibly. Due to this limitation, bioproduction plants and artificial organ modules are complicated, including peripheral auxiliary devices. However, there is a problem that it must be made large-scale.
JP-A-4-360682 JP-A-4-281784 JP 2004-135668 A JP 2006-25635 A JP2006-81468 JP 2003-180334 A Supervised by Michio Oishi "Animal cell culture technology and substance production" 2002 CMC Publishing

上記した従来の細胞培養担体には次のような課題がある。すなわち、従来の担体では、担体表面の接着面が凸面であるため、細胞の初期接着が悪く、また、細胞が不自然に伸展した形状をとるため細胞の状況に悪影響がある。さらに自己産生サイトカインが分散しやすい環境であるため、正常に近い細胞の担体への接着に困難が伴う。   The above-described conventional cell culture carrier has the following problems. That is, in the conventional carrier, since the adhesion surface of the carrier surface is convex, the initial adhesion of the cells is poor, and the cell condition is adversely affected because the cells take an unnaturally extended shape. Furthermore, since it is an environment in which self-produced cytokines are easy to disperse, it is difficult to adhere cells close to normal to carriers.

また、従来の細胞培養担体では担体の表面に細胞が接着しているため、担体同士、または担体と培養槽が接触した場合の物理的ダメージが避けられない。これらの問題を解決することを目指して発泡素材や繊維素材よりなる改良された細胞培養担体もあるものの、内部の空隙が発泡や繊維状物質を使用して形成された無秩序な構造であるため、空間の利用効率が悪く、また、細胞を高効率で均一に導入することが困難である問題がある。   Further, in the conventional cell culture carrier, since the cells are adhered to the surface of the carrier, physical damage is inevitable when the carriers are in contact with each other or when the carrier is in contact with the culture tank. Although there is an improved cell culture carrier made of foam material and fiber material aiming to solve these problems, because the internal voids are disordered structure formed using foam or fibrous material, There are problems in that space utilization efficiency is poor and it is difficult to introduce cells uniformly with high efficiency.

また、中空糸を用いた接着系細胞の培養方法では高密度の培養が可能であるが、中空糸内への接着系細胞の均一な導入のためには特別の工夫が必要であり、また培養時には強制的な培養液の循環が必要であるため細胞培養部分以外に、送液設備が別に必要となる。   In addition, although the culture method of adherent cells using hollow fibers enables high-density culture, special measures are required for the uniform introduction of adherent cells into the hollow fibers. In some cases, forced circulation of the culture solution is required, so that a separate liquid supply facility is required in addition to the cell culture portion.

本発明では上記した課題を解決するため、本発明で示す新規細胞培養担体を考案した。   In order to solve the above-described problems, the present invention has devised a novel cell culture carrier shown in the present invention.

すなわち、本発明は以下のような構成を有する。
(1)球体、楕円体、多面体、柱状体または錐体の外部形状を有する、最長径および最長径に垂直な方向の最大長が50〜2000μmの微小中空体の外部を切断した立体であって、中空部分に接着系細胞が接着可能な内壁を有し、外部形状表面に5〜40%の外空間と中空部分をつなぐ開口部を有する、細胞培養担体。
(2)中空部分がひと続きである(1)に記載の細胞培養担体。
(3)1つまたは2つの開口部を有する(1)または(2)に記載の細胞培養担体。
(4)外部形状が柱状体である(1)〜(3)に記載の細胞培養担体。
(5)中空糸を切断することにより製造される請求項1〜4のいずれかに記載の細胞培養担体。
(6)(1)〜(5)のいずれかに記載の細胞培養担体を用いて接着系細胞を培養する細胞培養方法。
(7)細胞培養担体を培地中に平面に並べることを特徴とする(6)に記載の細胞培養方法。
(8)前記中空糸を束ねて切断することで細胞培養担体を培地上に平面に並べることを特徴とする(7)に記載の細胞培養方法。
That is, the present invention has the following configuration.
(1) A solid body having an outer shape of a sphere, an ellipsoid, a polyhedron, a columnar body, or a cone, and the outside of a micro hollow body having a longest diameter and a maximum length in a direction perpendicular to the longest diameter of 50 to 2000 μm. A cell culture carrier having an inner wall capable of adhering adhesive cells in a hollow part, and an opening connecting the outer part and the hollow part of 5 to 40% on the outer shape surface.
(2) The cell culture carrier according to (1), wherein the hollow portion is continuous.
(3) The cell culture carrier according to (1) or (2), which has one or two openings.
(4) The cell culture carrier according to any one of (1) to (3), wherein the external shape is a columnar body.
(5) The cell culture carrier according to any one of claims 1 to 4, which is produced by cutting a hollow fiber.
(6) A cell culture method for culturing adhesive cells using the cell culture carrier according to any one of (1) to (5).
(7) The cell culture method according to (6), wherein the cell culture carriers are arranged in a plane in a medium.
(8) The cell culture method according to (7), wherein the cell culture carriers are arranged in a plane on a medium by bundling and cutting the hollow fibers.

本発明の細胞培養担体は既存の外周部に細胞を保持する細胞培養担体と比較し、初期の接着効率、細胞の生存率、増殖率、タンパク生産能などにおいて、正常な細胞の状態に近い効果が得られる。   The cell culture carrier of the present invention has an effect close to that of a normal cell in terms of initial adhesion efficiency, cell survival rate, proliferation rate, protein production ability, etc., compared with a cell culture carrier that retains cells on the existing outer periphery. Is obtained.

本発明の細胞培養担体は、球体、楕円体、多面体、柱状体または錐体の外部形状を有する最長径が50μm〜2000μmの微小中空体の外部を切断した立体であり、中空部分に接着系細胞が接着可能な内壁を有し、外部形状表面の5〜40%の部分に外空間と中空部分をつなぐ開口部を有する定められた形状であれば良い。   The cell culture carrier of the present invention is a solid obtained by cutting the outside of a micro hollow body having a longest diameter of 50 μm to 2000 μm having a spherical, ellipsoidal, polyhedral, columnar or pyramidal outer shape, and an adhesive cell is attached to the hollow part. May have a predetermined shape having an inner wall that can be bonded, and having an opening connecting the outer space and the hollow portion in a portion of 5 to 40% of the outer shape surface.

ここで「形状」とは担体の構成素材が存在する部分の形を示す。「外部形状」とは担体の「内空間」の立体形状を示す。内空間とは任意の空間地点(A)において、(A)を通過する任意の3次元内の直線のうち、担体に(A)の両端で交わるものが存在する場合、その地点を担体の「内空間」であると定義する。また、「内空間」で無い部分を「外空間」と称す。   Here, the “shape” indicates the shape of a portion where the constituent material of the carrier exists. “External shape” refers to the three-dimensional shape of the “internal space” of the carrier. What is the inner space? If there is a carrier that intersects at both ends of (A) among any three-dimensional straight lines passing through (A) at any space point (A), that point is designated as “ It is defined as “inner space”. A portion that is not an “inner space” is referred to as an “outer space”.

本発明の細胞培養担体の切断前の外部形状としては、球体、楕円体、多面体、柱状体または錐体であるが、前記外部形状であって、外部応力によって形状が柔軟に変化した形状についても前記外部形状に含まれる。ここでいう「柱状体」は円柱、楕円柱または多角柱の形状、「錘体」は円錐、楕円錘または多角錘の形状であると定義する。   The external shape before cutting of the cell culture carrier of the present invention is a sphere, an ellipsoid, a polyhedron, a columnar body or a cone, but the external shape is also a shape whose shape is flexibly changed by an external stress. Included in the external shape. The “columnar body” here is defined as the shape of a cylinder, an elliptical column or a polygonal column, and the “weight” is defined as the shape of a cone, an elliptical column or a polygonal column.

また「内空間」のうち担体では無い部分を「中空部分」と称する。中空部分においては培養液、または細胞が担体外部より進入しうるが再び外空間へと移行する際の自由度が制限されうる空間である。   A portion of the “inner space” that is not a carrier is referred to as a “hollow portion”. The hollow part is a space in which the culture solution or cells can enter from the outside of the carrier, but the degree of freedom when moving to the outer space again can be limited.

本発明の細胞培養担体では、この内空間に中空部分が存在し、担体の形は複雑であるが、外部形状に言及する場合、これらの中空部分により除外される部分については考えない。すなわち、担体部分と中空部分をあわせた内部空間を「外部形状」と称す。   In the cell culture carrier of the present invention, there are hollow portions in this inner space, and the shape of the carrier is complicated. However, when referring to the external shape, the portions excluded by these hollow portions are not considered. That is, the internal space combining the carrier portion and the hollow portion is referred to as “external shape”.

「微小中空体」とは内空間内に担体の構成素材の存在しない部分を有する微小な立体形状を示し、「微小」とはここでは2000μm以下の大きさであることを示す。構成素材の存在しない中空部分は1つであっても複数であっても良い。   “Micro hollow body” indicates a micro solid shape having a portion in which the constituent material of the carrier does not exist in the internal space, and “micro” indicates here that the size is 2000 μm or less. There may be one or a plurality of hollow portions where no constituent material exists.

中空部分が複数であるとは、担体内部にお互いに細胞の行き来出来ず連続でない複数の中空空間があることを意味する。連続部分が存在する場合でも連続部分を通じて細胞が行き来出来ない場合は複数の中空空間が存在するとみなす。   A plurality of hollow portions means that there are a plurality of non-continuous hollow spaces in which cells cannot move back and forth inside the carrier. Even if there is a continuous part, if cells cannot move through the continuous part, it is considered that there are a plurality of hollow spaces.

「開口部」とは中空部分と外空間の境界面の境界のうち、細胞が通過可能な部位を指す。   The “opening” refers to a site through which cells can pass among the boundary between the hollow part and the outer space.

担体内部の空隙率に関する制限はその他の条件を満たす限り無いが、本発明の細胞培養担体を使用する効果である高密度での細胞培養を実現するためには、その空隙率は高い方が好ましく、好ましくは50%以上、最も好ましくは80%以上である。   Although there are no restrictions on the porosity inside the carrier as long as other conditions are satisfied, it is preferable that the porosity is high in order to achieve high-density cell culture that is an effect of using the cell culture carrier of the present invention. , Preferably 50% or more, most preferably 80% or more.

ここでの「空隙率」とは「内空間」の中で「中空部分」の占める割合を示す。例えば、細胞培養担体の構成素材の占める体積が10であり、中空部分の体積が90、内空間の体積が100である場合、空隙率は90%であると算出される。   Here, the “void ratio” indicates the proportion of the “hollow portion” in the “inner space”. For example, when the volume occupied by the constituent material of the cell culture carrier is 10, the volume of the hollow portion is 90, and the volume of the inner space is 100, the porosity is calculated to be 90%.

「内壁」とは中空部分に存在する担体構成素材の表面を示す。   The “inner wall” indicates the surface of the carrier constituting material existing in the hollow portion.

「接着系細胞」とは、細胞の隣接部位に接着面が存在する場合、その接着面に接着する細胞を指す。主に多細胞生物の生体内に見られ、例を挙げると肝細胞、皮膚角質細胞、毛母細胞、口腔上皮細胞、食道上皮細胞、胃粘膜上皮細胞、小腸吸収上皮細胞、大腸吸収上皮細胞、胆管上皮細胞、すい臓インスリン分泌細胞、すい臓グルカゴン分泌細胞、骨細胞、軟骨細胞、平滑筋細胞、心筋細胞、筋肉衛星細胞、神経細胞、ホルモン分泌細胞、白色脂肪細胞、褐色脂肪細胞、骨髄などの初代培養細胞や、ES細胞、iPS細胞または成体幹細胞より分化誘導により作成した接着系細胞が挙げられ、これらに限らないが、壁面との接着形態により細胞活動が大きく影響を受ける細胞に本発明の細胞培養担体を適用することが好適であり、上記した中では肝細胞、口腔上皮細胞、食道上皮細胞、胃粘膜上皮細胞、小腸吸収上皮細胞、大腸吸収上皮細胞、胆管上皮細胞、すい臓インスリン分泌細胞、すい臓グルカゴン分泌細胞、ホルモン分泌細胞の初代培養細胞、ES細胞、iPS細胞または成体幹細胞より分化させた接着系細胞が好適である。また自然界に存在する細胞にセレクションをかけ作り出した株化細胞、生体内由来の正常細胞や株化細胞に遺伝子導入、遺伝子欠損を生じさせ人工的に作り出した細胞も自然界に存在する細胞と同様に好適に使用できる。株化接着系細胞の例を挙げると、チャイニーズハムスター卵巣細胞由来のCHO細胞、イヌ腎臓上皮細胞由来のMDCK細胞、マウス胎児皮膚由来のNIH3T3細胞、ラット副腎髄質由来のPC12細胞、ショウジョウバエ由来のS2細胞、蛾由来のSf9細胞、アフリカミドリザル腎臓由来のVero細胞、ヒト子宮ガン由来のHeLa細胞、ヒト結腸ガン由来のCaco−2細胞、ヒト肝ガン由来のHuh7細胞やHepG2細胞がある。   An “adhesive cell” refers to a cell that adheres to an adhesive surface when an adhesive surface is present at an adjacent site of the cell. It is mainly found in living organisms of multicellular organisms, such as hepatocytes, skin keratinocytes, hair matrix cells, oral epithelial cells, esophageal epithelial cells, gastric mucosal epithelial cells, small intestinal absorption epithelial cells, large intestine absorption epithelial cells, Bile duct epithelial cells, pancreatic insulin secreting cells, pancreatic glucagon secreting cells, bone cells, chondrocytes, smooth muscle cells, cardiomyocytes, muscle satellite cells, nerve cells, hormone secreting cells, white fat cells, brown fat cells, bone marrow, etc. Examples include, but are not limited to, cultured cells, ES cells, iPS cells, or adhesion-derived cells prepared by induction of adult stem cells. It is preferable to apply a culture carrier, among which hepatocytes, oral epithelial cells, esophageal epithelial cells, gastric mucosal epithelial cells, small intestine absorbing epithelial cells, large intestine absorbing epithelial cells Biliary epithelial cells, pancreatic insulin secreting cells, pancreatic glucagon secreting cells, primary culture cells of hormone-secreting cells, ES cells, adhesion system cells differentiated from iPS cells or adult stem cells are preferred. In addition, cell lines created by selecting cells that exist in nature, and cells created artificially by gene transfer and gene deletion in normal cells or cell lines derived from living organisms are the same as cells that exist in nature. It can be used suitably. Examples of established adherent cells include CHO cells derived from Chinese hamster ovary cells, MDCK cells derived from canine kidney epithelial cells, NIH3T3 cells derived from mouse fetal skin, PC12 cells derived from rat adrenal medulla, and S2 cells derived from Drosophila. , Sf9 cells derived from sputum, Vero cells derived from African green monkey kidney, HeLa cells derived from human uterine cancer, Caco-2 cells derived from human colon cancer, Huh7 cells and HepG2 cells derived from human liver cancer.

本発明の細胞培養担体は垂直な方向の最大長が50μm〜2000μmであるが、このサイズは接着系細胞を効率よく本発明の細胞培養担体に導入し、かつ、空間を効率的に使用するために適した大きさである。すなわち50μm以下のサイズであっては、個々の担体への細胞導入数が限られ培養時の空間の利用効率が低下する。また、培養時に培地との分離が困難となり効率が低下する。また2000μm以上のサイズを持つものは均一な細胞の導入に困難が伴い、内部の形状にもよるが空間の利用効率が低下する。好ましくはサイズが50μm〜1000μmの小片であり、もっとも好ましくは100μm〜500μmである。   The cell culture carrier of the present invention has a maximum length of 50 μm to 2000 μm in the vertical direction. This size is used to efficiently introduce adherent cells into the cell culture carrier of the present invention and efficiently use the space. The size is suitable for. That is, when the size is 50 μm or less, the number of cells introduced into individual carriers is limited, and the space utilization efficiency during culture is reduced. In addition, separation from the medium becomes difficult at the time of culture, and the efficiency is lowered. In addition, those having a size of 2000 μm or more are accompanied by difficulty in uniform cell introduction, and the space utilization efficiency is lowered depending on the internal shape. The size is preferably a small piece having a size of 50 μm to 1000 μm, and most preferably 100 μm to 500 μm.

本発明の細胞培養担体は開口部が5〜40%であるが、この性状は担体の中空部分と外空間との培養液の循環を部分的に抑制し、自己産生サイトカイン濃度を向上させること、また、担体への細胞導入時に必要な構成である。細胞培養担体の開口部が5%未満である場合、開口部が小さすぎるため細胞播種時の導入効率が低下し、また、細胞培養担体の開口部が40%を上回る場合も、細胞播種時の効率が低下し、また自己産生サイトカインの濃度上昇も期待できないため、好ましくない。   The cell culture carrier of the present invention has an opening of 5 to 40%, but this property partially suppresses the circulation of the culture solution between the hollow part and the outer space of the carrier, and improves the self-produced cytokine concentration, In addition, this is a necessary structure for introducing cells into the carrier. When the opening of the cell culture carrier is less than 5%, since the opening is too small, the introduction efficiency at the time of cell seeding is reduced, and when the opening of the cell culture carrier exceeds 40%, This is not preferable because efficiency is lowered and an increase in the concentration of self-produced cytokines cannot be expected.

本発明の細胞培養担体の外部形状は様々な形状が考えられるが、球形の外部形状を有する微小中空体を考えた場合、球形中空体上部に球状の開口部が存在する場合、球の半径の半分の半径を有する開口部が存在すると、開口部の表面積の割合はおよそ6.6%となり、これより遙かに小さい開口部を持つ細胞培養担体は細胞導入時の効率が著しく低下してしまう場合がある。また球状の中空体を中央部にて平面で切り取った半球の細胞培養担体を考えた場合、担体の厚みを考えなければ、開口部はおよそ33%となり、この形状よりも開口部が広い場合は形状によっては細胞の播種時の効率は高く保てるものの、細胞培養時の自己産生サイトカインの局所濃度を上昇する効果が得られにくい場合がある。したがって、本発明の細胞培養担体では開口部が外部形状面積に対し5〜40%であることが必要であるが、細胞培養担体の形状を考慮した場合、好ましくは5〜35%、より好ましくは10〜30%である。   Various shapes can be considered for the external shape of the cell culture carrier of the present invention. However, when a micro hollow body having a spherical external shape is considered, when a spherical opening is present at the top of the spherical hollow body, the radius of the sphere If there is an opening having a half radius, the ratio of the surface area of the opening is about 6.6%, and a cell culture carrier having an opening much smaller than this significantly reduces the efficiency at the time of cell introduction. There is a case. Also, when considering a hemispherical cell culture support in which a spherical hollow body is cut out in a plane at the center, the opening is about 33% if the thickness of the support is not considered, and the opening is wider than this shape. Although the efficiency at the time of cell seeding can be kept high depending on the shape, it may be difficult to obtain the effect of increasing the local concentration of the self-produced cytokine during cell culture. Therefore, in the cell culture carrier of the present invention, the opening needs to be 5 to 40% with respect to the external shape area. However, when considering the shape of the cell culture carrier, it is preferably 5 to 35%, more preferably 10-30%.

本発明の細胞培養担体の構成する構成素材に関しては、本発明の細胞培養担体の形状に成型可能なあらゆる素材が使用可能であり、素材の調整方法、平均分子量等制限はないが、好ましくは金属または高分子物質を利用することができる。ここで高分子とはゴム、多糖類、タンパク質、水溶性合成高分子、有機溶媒可溶性高分子が挙げられ、具体例を挙げるとセルロース、アラビアガム、トラガガントガム、カラギーナン、アガー、グアガム、カラヤガム、ローカストビーンガム、ペクチン、ガラクタン、マンナン、プルラン、キサンタンガム、ゼラチン、カゼイン、コンドロイチン硫酸、コラーゲン、エラスチン、フィブロイン、キトサン、キチン、ヒアルロン、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン、アルギン酸エステル、アルギン酸塩、ポリビニルアルコール、ポリビニルピロリドン、ポリビニルエチルエーテル、カルボキシビニルポリマー、ポリアクリル酸、ポリアクリルアミド、ポリスチレン、ポリ塩化ビニル、ポリ酢酸ビニル、ポリアクリロニトリル、ポリスルホン、ポリウレタン、メタクリル酸アクリル、フッ素系高分子、ポリアミド、ポリピペラジンアミド、ポリウレア、架橋ポリエーテル、ポリアクリロニトリルなどがある。好ましくはポリスルホン、メタクリル酸アクリルであり、より好ましくは本発明の実施例で使用されているポリスルホンである。   Regarding the constituent material constituting the cell culture carrier of the present invention, any material that can be molded into the shape of the cell culture carrier of the present invention can be used, and there are no restrictions on the material adjustment method, average molecular weight, etc. Alternatively, a polymer substance can be used. Here, the polymer includes rubber, polysaccharide, protein, water-soluble synthetic polymer, organic solvent-soluble polymer, and specific examples include cellulose, gum arabic, tragagant gum, carrageenan, agar, guar gum, karaya gum, locust bean. Gum, pectin, galactan, mannan, pullulan, xanthan gum, gelatin, casein, chondroitin sulfate, collagen, elastin, fibroin, chitosan, chitin, hyaluron, carboxymethyl starch, methylhydroxypropyl starch, alginate, alginate, polyvinyl alcohol, polyvinyl Pyrrolidone, polyvinyl ethyl ether, carboxyvinyl polymer, polyacrylic acid, polyacrylamide, polystyrene, polyvinyl chloride, polyvinyl acetate, polyacrylic Nitrile, polysulfone, polyurethane, acrylic methacrylic acid, fluorine-based polymers, polyamides, polypiperazine amides, polyureas, crosslinked polyether, and the like polyacrylonitrile. Preferred are polysulfone and acrylic methacrylate, and more preferred is polysulfone used in the examples of the present invention.

さらに本発明の細胞培養担体は単一の構成素材から構成されても良いし、細胞接着面だけ別の構成素材より構成されるなど複数の素材から構成されていても良い。例えば接着系細胞の接着性を向上させるために担体全体の表面または担体内部の表面のみを細胞接着性を向上させる別の構成素材でコーティングすることは好ましい。コーティング素材としては特に制限されるものでは無いが、コラーゲン、ゼラチン、フィブロネクチンによるコーティング、正電荷、負電荷の官能基の導入、各種の細胞接着因子、例えば、RGDペプチド(Arg−Gly−Asp)による修飾などは好ましい。   Furthermore, the cell culture carrier of the present invention may be composed of a single constituent material, or may be composed of a plurality of materials such as a cell adhesive surface composed of another constituent material. For example, in order to improve adhesion of adherent cells, it is preferable to coat the entire surface of the carrier or only the surface inside the carrier with another constituent material that improves cell adhesion. The coating material is not particularly limited, but is coated with collagen, gelatin, fibronectin, introduction of positively or negatively charged functional groups, various cell adhesion factors such as RGD peptide (Arg-Gly-Asp) Modification is preferred.

また本発明の細胞培養担体は、それぞれに開口部を持つ複数の内空隙が存在しても良いが、内空間において中空部分がひと続きである場合、すなわち中空部分が1つのみ存在する場合に細胞の導入効率、内部空間の効率的な利用が実現できるため高い性能を発揮することができるため、好ましい。ただし本発明の細胞培養担体のような微細な担体を多数個生産する過程では、製造時に生ずる個体差により一部の担体がひと続きでは無い内空間を有する場合もあり、このような場合も細胞培養担体の平均の中空部分の個数が1.5以下である場合はすべての細胞培養担体がひと続きの中空部分を持つ場合と同様の効果が得られるため好ましく、より好ましくは平均の中空部分の個数が1.1以下である。   The cell culture carrier of the present invention may have a plurality of inner voids each having an opening. However, when the hollow portion is continuous in the inner space, that is, when only one hollow portion is present. Since cell introduction efficiency and efficient use of the internal space can be realized, high performance can be exhibited, which is preferable. However, in the process of producing a large number of fine carriers such as the cell culture carrier of the present invention, some carriers may have internal spaces that are not continuous due to individual differences that occur during production. When the average number of hollow portions of the culture carrier is 1.5 or less, the same effect as when all the cell culture carriers have a continuous hollow portion can be obtained, and more preferably, the average hollow portion The number is 1.1 or less.

また本発明の細胞培養担体は、中空部分と外空間をつなぐ開口部が1つまたは2つであることが好ましい。開口部の個数は細胞培養担体の中空部分を通過する細胞、および細胞培養液の移動に関わっており、開口部が一つまたは2つである場合は細胞導入時の効率を高くするために有効であり、また担体内部の自己産生サイトカインの濃度を高く保つことができる。また開口部が2つの場合であっても細胞導入時に片側の開口部を閉鎖した状態を作り、高い効率で細胞を導入することが可能である。ただし多数個製造した担体のうち、製造時のばらつきにより一部が2以上の開口部を有する場合もその全体の平均数が2.5以下である場合は同様の機能が得られるため好ましく、より好ましくは平均が2.2以下である場合である。なお、中空部分と外空間をつなぐ部分のうち、構成物が存在しないが、細胞が透過できるほどの大きさの無い微細な孔構造の存在は制限されるものではない。細胞の種類や培養方法によっては、これらの細胞が透過出来ない孔は培養液の流通を促進するため望ましいことがある。   The cell culture carrier of the present invention preferably has one or two openings that connect the hollow portion and the outer space. The number of openings is related to the movement of cells passing through the hollow part of the cell culture carrier and the cell culture medium. If there are one or two openings, it is effective to increase the efficiency during cell introduction. In addition, the concentration of the self-produced cytokine inside the carrier can be kept high. Even if there are two openings, it is possible to introduce a cell with high efficiency by creating a state in which the opening on one side is closed at the time of cell introduction. However, among a plurality of produced carriers, even when some of the carriers have two or more openings due to variations in production, it is preferable because the same function can be obtained if the overall average number is 2.5 or less. Preferably, the average is 2.2 or less. In addition, although a structure does not exist among the parts which connect a hollow part and external space, presence of the fine pore structure which does not have a size which can permeate | transmit a cell is not restrict | limited. Depending on the type of cell and the culture method, pores that cannot be permeated by these cells may be desirable because they facilitate the flow of the culture solution.

また本発明の細胞培養担体は、形状が柱状体であることが好ましい。本発明の細胞培養担体に効率的に細胞を播種するためには後述するように密集した状態で開口部を揃えた状態をとらせることが好ましい使用方法であるが、柱状体はこの用途において適した形状であり、より好ましくは図2に示す柱状体の外形を有する細胞培養担体である。ただし端部には微細な例外部分が存在することは本体部分が柱状体であるかぎり許容される。柱状体の直径としては100〜1000μmであることが好ましく、200〜500μmであることがより好ましい。   The cell culture carrier of the present invention is preferably a columnar body. In order to efficiently seed cells on the cell culture carrier of the present invention, it is preferable to use a state where the openings are aligned in a dense state as described later, but the columnar body is suitable for this application. More preferably, it is a cell culture carrier having the columnar outer shape shown in FIG. However, the presence of a fine exceptional portion at the end portion is allowed as long as the main body portion is a columnar body. The diameter of the columnar body is preferably 100 to 1000 μm, and more preferably 200 to 500 μm.

本発明の細胞培養担体の製造方法としては、鋳型を用いた製造や、リソグラフィーによる製造、類似構造を持った自然界天然構造物の加工、前駆構造物の切断による製造が挙げられる。中でも、本発明の細胞培養担体の好ましい態様である、前記柱状体の形状を有する細胞培養担体は、中空糸を切断することによって好ましく製造される。例えば、長さ100000μmの形状を有する中空糸を切断した場合、長さ50μmの本発明の細胞培養担体を2000個製造することができる。製造効率を考えた場合、中空糸の長さは長い方が好ましく、好ましくは最終的に得られる細胞培養担体の最長径に垂直な方向の最大長の100倍以上の長さの中空糸を切断して生産することであり、より好ましくは1000倍以上の長さの中空糸を切断して生産する方法である。   Examples of the method for producing a cell culture carrier of the present invention include production using a template, production by lithography, processing of a natural structure having a similar structure, and production by cutting a precursor structure. Among them, the cell culture carrier having the columnar shape, which is a preferred embodiment of the cell culture carrier of the present invention, is preferably produced by cutting a hollow fiber. For example, when a hollow fiber having a length of 100000 μm is cut, 2000 cell culture carriers of the present invention having a length of 50 μm can be produced. In consideration of production efficiency, it is preferable that the length of the hollow fiber is long. Preferably, the hollow fiber having a length of 100 times or more of the maximum length in the direction perpendicular to the longest diameter of the finally obtained cell culture carrier is cut. More preferably, it is a method of cutting and producing a hollow fiber having a length of 1000 times or more.

また中空糸から細胞培養担体を作製する段階で、中空糸を束ねた状態で切断することも好適な製造方法の1つである、開口部の方向を揃えた細胞培養担体が密集した集合体を効率的に生産することができる。中空糸を束ねて切断することにより作製した後は、そのまま細胞培養担体として用いることもできるし、表面修飾、片方の開口部を閉じるなどの処理を行い細胞培養担体として用いることもできる。   Moreover, in the step of producing the cell culture carrier from the hollow fiber, one of the preferable production methods is to cut the hollow fiber in a bundled state. It can be produced efficiently. After being produced by bundling and cutting the hollow fiber, it can be used as it is as a cell culture carrier, or it can be used as a cell culture carrier after being subjected to treatment such as surface modification and closing one of the openings.

また本発明は前記細胞培養担体を用いて接着系細胞を培養する細胞培養方法に関する。ここでいう細胞培養とは、酸素、栄養素等を含む培養液等を介して担体内部に保持した接着系細胞の生存を維持することを示す。また、培養の形態としては、細胞培養に一般的に用いられる培養槽を使用することができ、具体的にはペトリ皿、プラスチックプレート、プラスチックチューブ、ガラスチューブ、中空糸繊維、スパイラルフィルム、カラム、マルチウェルプレート、マルチシートプレート、細胞生育生産物生産のために用いられる攪拌培養用の培養チャンバー、各種細胞アッセイ機材の細胞保持部分などが挙げられるがこれらに限らず、細胞の生存に適した環境であれば良い。また、細胞培養に使用する培地についても、細胞の生存に適した培地であれば特に制限されない。   The present invention also relates to a cell culture method for culturing adherent cells using the cell culture carrier. Cell culture as used herein refers to maintaining the survival of adherent cells held inside the carrier via a culture solution containing oxygen, nutrients, and the like. In addition, as a culture form, a culture tank generally used for cell culture can be used. Specifically, a Petri dish, a plastic plate, a plastic tube, a glass tube, a hollow fiber, a spiral film, a column, Examples include, but are not limited to, multiwell plates, multi-sheet plates, agitation culture chambers used to produce cell growth products, and cell holding parts of various cell assay equipment. If it is good. The medium used for cell culture is not particularly limited as long as it is a medium suitable for cell survival.

本発明の細胞培養方法においては、前記細胞培養担体の形状的特徴を活かすことで、前記細胞培養担体を培地中に平面に並べることができる。ここでいう「培地中に平面に並べる」とは、細胞培養担体の大部分が重ならずに整列していることであり、例えば、円筒状の培養槽の外壁に整列した状態も含まれる。柱状体の細胞培養担体を密集した状態で開口部の方向を揃えた状態にして細胞を播種した場合、接着系細胞を播種する過程で高い効率をもって細胞を細胞培養担体に接着させることが可能であり本発明の細胞培養担体を効率的に利用することができるため好ましい。細胞培養担体を、開口部を揃えて密集した状態で集合させる方法としては、開口部を揃え密集した状態の集合として製造する方法や、作製した細胞培養担体を後から集合させる方法が考えられるが、好ましくは密集した集合として作製する方法である。   In the cell culture method of the present invention, the cell culture carrier can be arranged in a plane in the medium by taking advantage of the shape characteristics of the cell culture carrier. Here, “arranging in a plane in the medium” means that most of the cell culture carriers are aligned without overlapping, and includes, for example, a state where they are aligned on the outer wall of a cylindrical culture tank. When the cells are seeded with the columnar cell culture support closely packed and the direction of the openings aligned, it is possible to adhere the cells to the cell culture support with high efficiency in the process of seeding the adherent cells. It is preferable because the cell culture carrier of the present invention can be used efficiently. As a method for assembling the cell culture carrier in a state where the openings are aligned and dense, a method for producing the cell culture carrier as a collection in which the openings are aligned and dense, or a method for assembling the prepared cell culture carrier later can be considered. Preferably, it is a method of producing as a dense assembly.

本発明の細胞培養担体に細胞を導入する方法に関しては特に限定されず、細胞培養担体の開口部に細胞懸濁液を滴下して重力により導入する方法、細胞培養担体に細胞懸濁液を加えて遠心力を用いて導入する方法が挙げられるが、細胞培養担体を培地中に平面に並べた場合、開口部を固定面と反対方向の一方向に向けて整列させておくことで、上部より細胞懸濁液を滴下することで、重力により細胞が効率よく細胞培養担体に導入されうる。   The method for introducing cells into the cell culture carrier of the present invention is not particularly limited, and a method in which a cell suspension is dropped into the opening of the cell culture carrier and introduced by gravity, or the cell suspension is added to the cell culture carrier. However, when cell culture carriers are arranged in a flat plane in the medium, the openings are aligned in one direction opposite to the fixed surface. By dropping the cell suspension, the cells can be efficiently introduced into the cell culture carrier by gravity.

本発明の細胞培養方法の好ましい態様である、細胞培養担体を培地中に平面に並べる方法に関しては特に限定されず、培養槽平面に一時的に固定する方法、磁気や重力、遠心力等などを用いて培養槽に固定せずに整列させる方法が挙げられるが、好ましくは培養槽平面に一時的に固定する方法である。   There is no particular limitation on the method of arranging the cell culture carrier in a flat plane in the culture medium, which is a preferred embodiment of the cell culture method of the present invention, such as a method of temporarily fixing it on the plane of the culture tank, magnetism, gravity, centrifugal force, etc. Examples of the method include aligning without fixing to a culture tank, and a method of temporarily fixing to a culture tank plane is preferable.

なお本発明の細胞培養方法においては、細胞培養のために本発明の細胞培養担体に接着させた接着系細胞を凍結保存する場合も細胞培養の一部である。凍結の方法は問わないが、好ましくは−80℃以下での凍結であり、より好ましくは−150℃以下での凍結である。   In the cell culture method of the present invention, the case where the adherent cells adhered to the cell culture carrier of the present invention are cryopreserved for cell culture is also part of the cell culture. The method of freezing is not limited, but is preferably freezing at −80 ° C. or lower, more preferably freezing at −150 ° C. or lower.

以下に本発明の詳細を説明するため実施例を挙げるが、本発明は実施例に限定されるものではない。   Examples are given below to describe the details of the present invention, but the present invention is not limited to the Examples.

実施例1 細胞培養担体の作成
<方法>
外径400μm、内径300μmのポリスルホン中空糸(東レ、“トレビーノ”用)を隙間の空かないように束ねた後、凍結切片封入剤(ティッシュテックOCTコンパウンド(サクラファインテック社))に浸沈させ、十分にコンパウンドが浸透するまで数時間静置した。束ねた状態を保ったまま−150℃にて凍結し、十分に凍結させた凍結ブロックを凍結切片作成機(OTF5000(ブライト社英国))にて−20℃で、カーボンブレード(ミクロトーム用替え刃C35(フェザー社))をもちいて20μmの厚さに切断した。切断した中空糸集合体は、水溶性接着剤(シリル化ウレタン樹脂接着剤(“ボンドニューハイテック”(コニシ)))を薄く塗布したスライドガラス(シランコーティングスライドS3003(Dako))上に固定し、乾燥させた。
Example 1 Preparation of Cell Culture Carrier <Method>
After bundling polysulfone hollow fiber (for Toray, “Trevino”) with an outer diameter of 400 μm and an inner diameter of 300 μm so as not to leave a gap, it is immersed in a frozen section mounting agent (Tissuetech OCT Compound (Sakura Finetech)) It was allowed to stand for several hours until the compound sufficiently penetrated. While maintaining the bundled state, the frozen block was frozen at −150 ° C. and the frozen block was sufficiently frozen at −20 ° C. with a frozen section preparation machine (OTF5000 (Bright UK)), carbon blade (replacement blade C35 for microtome) (Feather)) and cut to a thickness of 20 μm. The cut hollow fiber assembly is fixed on a slide glass (Silane coated slide S3003 (Dako)) thinly coated with a water-soluble adhesive (silylated urethane resin adhesive (“Bond New Hitech” (Konishi))), Dried.

スライドガラス上で十分に乾燥させた細胞培養担体は純水に数時間浸して切断時に使用した凍結切片封入剤を除去した。その後、細胞培養担体は固定したスライドガラスと共にオートクレーブにて120℃、20分間処理を行い滅菌し、使用まで室温で保存した。   The cell culture carrier sufficiently dried on the slide glass was immersed in pure water for several hours to remove the frozen section mounting agent used at the time of cutting. Thereafter, the cell culture carrier was sterilized by treatment at 120 ° C. for 20 minutes in an autoclave together with the fixed slide glass, and stored at room temperature until use.

<結果>
作成した細胞培養担体の電子顕微鏡写真(日立S4800)を図3Aに、実体顕微鏡により撮影した写真を図3Bに示す。この細胞培養担体は外径が400μm、内径が300μm、高さがおよそ300μmであり開口部の比率はおよそ29%である。細胞培養担体は開口部を上下に向けた状態で密な状態でスライドガラス上に固定されており(図3C)、切断やオートクレーブ処理による乱れは生じなかった。また、スライドガラス上に水溶性接着剤により固定した細胞培養担体は数時間、細胞培養培地に浸した状態を経た後は、弱い水流などにより容易にスライドガラス上から遊離し、分散状態になった(図3D)
実施例2 細胞培養担体へのCaco―2細胞の播種
10cm細胞培養プレート(ファルコン社)上にて培養培地(DMEM/10%FBS(ギブコ社))にて培養したCaco−2細胞(ヒト結腸由来株化細胞細胞)を細胞剥離溶液(0.25%トリプシン/EDTA(シグマ社))処理しプレートから遊離させた。培養培地にて2回洗浄し残存する細胞剥離溶液を除去した。1000万個のヒト結腸ガン由来Caco−2細胞を10mlの培養培地に懸濁した。
<Result>
An electron micrograph (Hitachi S4800) of the prepared cell culture carrier is shown in FIG. 3A, and a photograph taken with a stereomicroscope is shown in FIG. 3B. This cell culture carrier has an outer diameter of 400 μm, an inner diameter of 300 μm, a height of about 300 μm, and an opening ratio of about 29%. The cell culture carrier was fixed on the slide glass in a dense state with the opening facing up and down (FIG. 3C), and no disturbance due to cutting or autoclaving occurred. In addition, the cell culture carrier fixed with a water-soluble adhesive on the slide glass was easily released from the slide glass by a weak water flow after being immersed in the cell culture medium for several hours and became dispersed. (Fig. 3D)
Example 2 Seeding of Caco-2 cells on cell culture carrier Caco-2 cells (derived from human colon) cultured in a culture medium (DMEM / 10% FBS (Gibco)) on a 10 cm cell culture plate (Falcon) The cell line was treated with a cell detachment solution (0.25% trypsin / EDTA (Sigma)) and released from the plate. The remaining cell detachment solution was removed by washing twice with the culture medium. Ten million human colon cancer-derived Caco-2 cells were suspended in 10 ml of culture medium.

細胞培養担体を密に整列させたスライドガラスは10cm細胞培養プレート(ファルコン社)中央に配置し、0.3%細胞培養用I型コラーゲン溶液(“セルゲン”(高研))を滴下し、常温で2時間静置し、細胞培養担体表面をコラーゲンでコートした。添加したコラーゲン溶液を除去し、滅菌したリン酸緩衝液で細胞培養担体を洗浄した。細胞培養担体の上部より少量ずつCaco−2細胞分散液を滴下した。添加後、30分間静置しCaco−2細胞が底に沈み、細胞培養担体の中に導入されるのを待ち、細胞培養担体を固定したスライドガラスを50mlチューブ(コーニング社)に移し、培養培地を満たした状態で、スライドガラスが垂直になる状態を保って培養インキュベーター(NAPCO CO26000)の中で37℃、CO濃度5%を保ち24時間培養した。 The slide glass with the cell culture carrier closely aligned is placed in the center of a 10 cm cell culture plate (Falcon), and a 0.3% type I collagen solution for cell culture (“Selgen” (Koken)) is added dropwise at room temperature. The cell culture carrier surface was coated with collagen. The added collagen solution was removed, and the cell culture carrier was washed with a sterilized phosphate buffer. A small amount of Caco-2 cell dispersion was dropped from the top of the cell culture carrier. After the addition, the mixture is allowed to stand for 30 minutes, and Caco-2 cells settle on the bottom and is introduced into the cell culture carrier. The slide glass on which the cell culture carrier is fixed is transferred to a 50 ml tube (Corning), and the culture medium. In a state in which the slide glass was satisfied, the slide glass was maintained in a vertical state, and the cells were cultured for 24 hours in a culture incubator (NAPCO CO26000) at 37 ° C. and 5% CO 2 concentration.

24時間後、50mlチューブのふたを開け、穏やかに溶液を懸濁することでスライドガラスより細胞培養担体を遊離させた。細胞培養担体を除去したスライドガラスは取り除き、50mlチューブ内を3000回転/分、5分間遠心し細胞培養担体を沈殿させ、培養液を取り除く作業を3回行った。   After 24 hours, the lid of the 50 ml tube was opened, and the cell culture carrier was released from the slide glass by gently suspending the solution. The slide glass from which the cell culture carrier was removed was removed, and the inside of the 50 ml tube was centrifuged at 3000 rpm for 5 minutes to precipitate the cell culture carrier, and the operation of removing the culture solution was performed three times.

<結果>
Caco−2細胞を接着させた細胞培養担体の凍結切片を作成した図4Bに、細胞を接着させた細胞培養担体の走査型電子顕微鏡にて観察した像を図4Aに示す。
細胞培養担体の上部よりCaco−2細胞懸濁液を滴下することにより、一部の細胞が細胞培養担体の内部に導入された。その後、細胞培養担体の内壁に接着させるために細胞培養担体を固定したスライドガラスを垂直に保ち、培養することで、内部に導入されたCaco−2細胞が細胞培養担体内部に生着することが確認された。
<Result>
FIG. 4B shows a frozen section of a cell culture carrier to which Caco-2 cells are adhered, and FIG. 4A shows an image observed with a scanning electron microscope of the cell culture carrier to which cells are adhered.
Some cells were introduced into the cell culture carrier by dropping the Caco-2 cell suspension from the top of the cell culture carrier. Thereafter, the Caco-2 cells introduced inside can be engrafted inside the cell culture carrier by keeping the glass slide on which the cell culture carrier is fixed in order to adhere to the inner wall of the cell culture carrier. confirmed.

実施例3 細胞培養担体を用いた接着系細胞の懸濁培養
<方法>
Caco−2細胞を内壁に接着させた細胞培養担体とCaco−2細胞単独の攪拌浮遊培養時の細胞生存率の推移を比較評価した。
Example 3 Suspension culture of adherent cells using cell culture carrier <Method>
The transition of cell viability during stirring suspension culture of a cell culture carrier having Caco-2 cells adhered to the inner wall and Caco-2 cells alone was compared and evaluated.

実施例2で調製した細胞培養担体と、実施例1と同様の方法で10cm細胞培養プレートで培養し、細胞剥離溶液にて回収したCaco−2細胞を、それぞれ180G、5分間の遠心を3回行い、細胞を洗浄した後、それぞれの細胞を6つのチューブにわけ、培養インキュベーターの中に設置した転倒混和型ローテーターにより30回転/分の速度で懸濁培養を行った。そして培養開始後0、1、3、6、24、48時間後の細胞を回収し180G5分間の遠心で細胞および細胞培養担体を沈殿させた後、培養液を除去し−30℃で凍結保存した。すべてのサンプルがそろった48時間後、サンプルを解凍し細胞生存率測定キット(セルカウンティングキット(WST−8)(同仁化学))とプレート吸光度計(マルチスキャンJX(サーモラボラトリー社))を用いて細胞の生存量を測定した。   Caco-2 cells cultured in a 10 cm cell culture plate in the same manner as in Example 1 and the cell culture carrier prepared in Example 2 and recovered in the cell detachment solution were centrifuged at 180 G for 5 minutes each 3 times. After the cells were washed, each cell was divided into 6 tubes, and suspension culture was performed at a rate of 30 rotations / minute with an inversion mixing rotator installed in a culture incubator. After 0, 1, 3, 6, 24, and 48 hours after the start of culture, the cells and the cell culture carrier were precipitated by centrifugation at 180 G for 5 minutes, and then the culture solution was removed and stored frozen at -30 ° C. . 48 hours after all samples were collected, the samples were thawed and used using a cell viability measurement kit (Cell Counting Kit (WST-8) (Dojindo)) and a plate absorptiometer (Multiscan JX (Thermo Laboratories)). Cell viability was measured.

<結果>
それぞれの細胞生存率の変化を図5に示す。細胞培養担体を用いないCaco−2細胞の生存率はアッセイ開始直後より急激に減少し24時間後には20%以下となった。これに対し、細胞培養担体に接着させたCaco−2細胞の生存率は培養開始後にある程度の減少が見られるが、その後、上昇傾向にあり、細胞培養担体内での生存が維持され細胞増殖が起きていた。
<Result>
The change of each cell viability is shown in FIG. The survival rate of Caco-2 cells without using a cell culture carrier decreased rapidly from immediately after the start of the assay, and became 20% or less after 24 hours. On the other hand, the survival rate of Caco-2 cells adhered to the cell culture carrier shows a certain decrease after the start of the culture, but thereafter, it tends to increase, and the survival in the cell culture carrier is maintained and the cell proliferation is not increased. It had occurred.

本発明の細胞培養担体の要件を満たす形状の例。AとBの2種類の例を示す。上図の三次元概念図において斜線部分は内壁面を示す。下図は上図の断面概念図、細胞An example of a shape satisfying the requirements of the cell culture carrier of the present invention. Two examples of A and B are shown. In the three-dimensional conceptual diagram in the upper diagram, the hatched portion indicates the inner wall surface. The figure below is a schematic cross-sectional view of the above figure, cells 本発明の細胞培養担体の要件を満たす形状の例、A、B、C、D、E、Fの6種類を示す。図の三次元概念図において斜線部は内壁面を示す。Examples of shapes that satisfy the requirements of the cell culture carrier of the present invention, A, B, C, D, E, and F, are shown. In the three-dimensional conceptual diagram in the figure, the hatched portion indicates the inner wall surface. 実施例1により作成した細胞培養担体の走査型電子顕微鏡写真(A)、実体顕微鏡写真(B)、スライドガラス上に整列させた細胞培養担体(C)、水溶液に分散させた細胞培養担体(D)である。Scanning electron micrograph (A), stereomicrograph (B), cell culture carrier (C) aligned on a glass slide, cell culture carrier (D) dispersed in an aqueous solution of the cell culture carrier prepared in Example 1 ). 実施例2によりCaco−2細胞を接着させた細胞培養担体の走査型電子顕微鏡写真(A)、凍結切片の可視光観察像(B)である。2 is a scanning electron micrograph (A) of a cell culture carrier to which Caco-2 cells are adhered according to Example 2, and a visible light observation image (B) of a frozen section. 実施例3による本発明の細胞培養担体と、細胞単独の攪拌培養時のCaco−2細胞生存率の変化結果である。It is a change result of the Caco-2 cell survival rate at the time of the stir culture of the cell culture carrier of this invention by Example 3 and a cell alone.

Claims (8)

球体、楕円体、多面体、柱状体または錐体の外部形状を有する、最長径および最長径に垂直な方向の最大長が50〜2000μmの微小中空体の外部を切断した立体であって、中空部分に接着系細胞が接着可能な内壁を有し、外部形状表面に5〜40%の外空間と中空部分をつなぐ開口部を有する、細胞培養担体。   A solid body having a spherical shape, an ellipsoid shape, a polyhedron shape, a columnar shape, or a pyramid shape, the longest diameter and the outside of a micro hollow body having a maximum length in a direction perpendicular to the longest diameter of 50 to 2000 μm, and having a hollow portion A cell culture carrier having an inner wall to which adherent cells can adhere, and an opening connecting the outer space and the hollow portion of 5 to 40% on the outer shape surface. 中空部分がひと続きである請求項1に記載の細胞培養担体。   The cell culture carrier according to claim 1, wherein the hollow portion is continuous. 1つまたは2つの開口部を有する請求項1または2に記載の細胞培養担体。   The cell culture carrier according to claim 1 or 2, which has one or two openings. 外部形状が柱状体である請求項1〜3のいずれかに記載の細胞培養担体。   The cell culture carrier according to any one of claims 1 to 3, wherein the external shape is a columnar body. 中空糸を切断することにより製造される請求項1〜4のいずれかに記載の細胞培養担体。   The cell culture carrier according to any one of claims 1 to 4, which is produced by cutting a hollow fiber. 請求項1〜5のいずれかに記載の細胞培養担体を用いて接着系細胞を培養する細胞培養方法。   A cell culture method for culturing adhesive cells using the cell culture carrier according to claim 1. 細胞培養担体を培地中に平面に並べることを特徴とする請求項6に記載の細胞培養方法。   The cell culture method according to claim 6, wherein the cell culture carriers are arranged in a plane in the medium. 前記中空糸を束ねて切断することで細胞培養担体を培地上に平面に並べることを特徴とする請求項7に記載の細胞培養方法。   The cell culture method according to claim 7, wherein the cell culture carriers are arranged in a plane on a medium by bundling and cutting the hollow fibers.
JP2008103472A 2008-04-11 2008-04-11 Carrier for cell culture Pending JP2009247334A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008103472A JP2009247334A (en) 2008-04-11 2008-04-11 Carrier for cell culture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008103472A JP2009247334A (en) 2008-04-11 2008-04-11 Carrier for cell culture

Publications (1)

Publication Number Publication Date
JP2009247334A true JP2009247334A (en) 2009-10-29

Family

ID=41308610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008103472A Pending JP2009247334A (en) 2008-04-11 2008-04-11 Carrier for cell culture

Country Status (1)

Country Link
JP (1) JP2009247334A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8701014B1 (en) 2002-11-18 2014-04-15 Facebook, Inc. Account linking
US8775560B2 (en) 2002-11-18 2014-07-08 Facebook, Inc. Host-based intelligent results related to a character stream
US9070118B2 (en) 2003-09-05 2015-06-30 Facebook, Inc. Methods for capturing electronic messages based on capture rules relating to user actions regarding received electronic messages
US9319356B2 (en) 2002-11-18 2016-04-19 Facebook, Inc. Message delivery control settings
US9516125B2 (en) 2003-03-26 2016-12-06 Facebook, Inc. Identifying and using identities deemed to be known to a user
US9571439B2 (en) 2002-11-18 2017-02-14 Facebook, Inc. Systems and methods for notification delivery
US9667585B2 (en) 2002-11-18 2017-05-30 Facebook, Inc. Central people lists accessible by multiple applications
JP2020511977A (en) * 2017-03-28 2020-04-23 コーニング インコーポレイテッド Aseptic bioprocess package
CN111206014A (en) * 2020-04-01 2020-05-29 中国烟草总公司郑州烟草研究院 Bionic alveolar culture method and culture device
CN113189317A (en) * 2021-04-29 2021-07-30 广东省人民医院 Experimental device for three-dimensional static culture of artificial blood vessel and use method thereof

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9171064B2 (en) 2002-11-18 2015-10-27 Facebook, Inc. Intelligent community based results related to a character stream
US9729489B2 (en) 2002-11-18 2017-08-08 Facebook, Inc. Systems and methods for notification management and delivery
US8701014B1 (en) 2002-11-18 2014-04-15 Facebook, Inc. Account linking
US8954530B2 (en) 2002-11-18 2015-02-10 Facebook, Inc. Intelligent results related to a character stream
US8954531B2 (en) 2002-11-18 2015-02-10 Facebook, Inc. Intelligent messaging label results related to a character stream
US9047364B2 (en) 2002-11-18 2015-06-02 Facebook, Inc. Intelligent client capability-based results related to a character stream
US9053174B2 (en) 2002-11-18 2015-06-09 Facebook, Inc. Intelligent vendor results related to a character stream
US9053173B2 (en) 2002-11-18 2015-06-09 Facebook, Inc. Intelligent results related to a portion of a search query
US9053175B2 (en) 2002-11-18 2015-06-09 Facebook, Inc. Intelligent results using a spelling correction agent
US9319356B2 (en) 2002-11-18 2016-04-19 Facebook, Inc. Message delivery control settings
US9075868B2 (en) 2002-11-18 2015-07-07 Facebook, Inc. Intelligent results based on database queries
US9075867B2 (en) 2002-11-18 2015-07-07 Facebook, Inc. Intelligent results using an assistant
US8819176B2 (en) 2002-11-18 2014-08-26 Facebook, Inc. Intelligent map results related to a character stream
US9774560B2 (en) 2002-11-18 2017-09-26 Facebook, Inc. People lists
US9769104B2 (en) 2002-11-18 2017-09-19 Facebook, Inc. Methods and system for delivering multiple notifications
US8775560B2 (en) 2002-11-18 2014-07-08 Facebook, Inc. Host-based intelligent results related to a character stream
US9571439B2 (en) 2002-11-18 2017-02-14 Facebook, Inc. Systems and methods for notification delivery
US9571440B2 (en) 2002-11-18 2017-02-14 Facebook, Inc. Notification archive
US9667585B2 (en) 2002-11-18 2017-05-30 Facebook, Inc. Central people lists accessible by multiple applications
US9531826B2 (en) 2003-03-26 2016-12-27 Facebook, Inc. Managing electronic messages based on inference scores
US9736255B2 (en) 2003-03-26 2017-08-15 Facebook, Inc. Methods of providing access to messages based on degrees of separation
US9516125B2 (en) 2003-03-26 2016-12-06 Facebook, Inc. Identifying and using identities deemed to be known to a user
US9070118B2 (en) 2003-09-05 2015-06-30 Facebook, Inc. Methods for capturing electronic messages based on capture rules relating to user actions regarding received electronic messages
JP7262395B2 (en) 2017-03-28 2023-04-21 コーニング インコーポレイテッド Aseptic bioprocess package
JP2020511977A (en) * 2017-03-28 2020-04-23 コーニング インコーポレイテッド Aseptic bioprocess package
CN111206014A (en) * 2020-04-01 2020-05-29 中国烟草总公司郑州烟草研究院 Bionic alveolar culture method and culture device
CN113189317A (en) * 2021-04-29 2021-07-30 广东省人民医院 Experimental device for three-dimensional static culture of artificial blood vessel and use method thereof

Similar Documents

Publication Publication Date Title
JP2009247334A (en) Carrier for cell culture
JP7219303B2 (en) Culture method
Joseph et al. Two-dimensional (2D) and three-dimensional (3D) cell culturing in drug discovery
Pampaloni et al. Three-dimensional tissue models for drug discovery and toxicology
EP3515600B1 (en) Organoid arrays
US10696943B2 (en) Method, device and kit for mass cultivation of cells using polyimide porous membrane
AU2004260106B2 (en) Automated cell culture system and process
RU2615179C2 (en) Devices and methods of cell culturing
Kumar et al. Large scale industrialized cell expansion: producing the critical raw material for biofabrication processes
CN112940940B (en) Cell culture method and kit
CN107257850A (en) High flux aggregation and the device of operation for mammalian cell
CN113142187B (en) Long-term culture and cryopreservation method of cells using polyimide porous membrane
WO2006106748A1 (en) Method for production of biological organic material and culture vessel
MX2013011967A (en) Methods and systems for harvesting cells.
Pörtner et al. An overview on bioreactor design, prototyping and process control for reproducible three-dimensional tissue culture
LEE et al. Optimization of Chitosan-Alginate Encapsulation Process Using Pig Hepatocytes or Development of Bioartificial Liver
CN112980689A (en) Adherent cell culture device, 2.5D beehive type culture system and method
JP6288311B2 (en) Substance production method
EP3098304A1 (en) Hybrid cell detachment-free cell expansion system for adherent cell culturing and related proceeding protocol
TW202122569A (en) Cell culturing method using small-piece porous membrane
WO2020008723A1 (en) Method for producing cell structure, carrier, and method for producing carrier
Felder et al. Automated cell culture system and process
Schmidt et al. Bioactive microgels for large-scale eukaryotic cell culture
JP2004147552A (en) Method for cell culture
Goosen Growth of Insect and Plant Cells Immobilised Using Electrified Liquid Jets